Targeted RNA-Seq of expression markers in NSCLC FFPE tumors requires integrated reagents, protocols, and interpretive software that can ensure consistent results across laboratories.

Download our poster to learn about this study, where a comprehensive targeted NGS system, the QuantideX® NGS RNA Lung Cancer Kit (RUO)*, was evaluated in 5 laboratories to assess accuracy and reproducibility.

Meet the Authors:
Victor Weigman, Ph.D., Director, Translational Genomics
Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics
Tom Halsey
Dan Su
Maria Curtis

Complete the form below to access this scientific poster